CRTAM Polyclonal Antibody

The CRTAM gene is upregulated in CD4 (see MIM 186940)-positive and CD8 (see CD8A; MIM 186910)-positive T cells and encodes a type I transmembrane protein with V and C1-like Ig domains (Yeh et al., 2008

The CRTAM Polyclonal Antibody is a highly reliable and efficient tool designed for the detection and analysis of CRTAM protein expression in various biological samples. This antibody is produced using advanced techniques, ensuring exceptional specificity and sensitivity.

The CRTAM Polyclonal Antibody exhibits outstanding performance in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. It enables researchers to accurately investigate the expression patterns and cellular localization of CRTAM in different tissues and cell types.

With its superior quality, this antibody guarantees consistent and reproducible results, making it an ideal choice for both basic research and clinical studies. Its exceptional affinity and selectivity enable precise identification and quantification of CRTAM, facilitating a deeper understanding of its biological functions and potential implications in various diseases.

The CRTAM Polyclonal Antibody is manufactured under strict quality control standards, ensuring batch-to-batch consistency and reliability. It is supplied in a convenient and ready-to-use format, allowing for easy integration into laboratory workflows.

In summary, the CRTAM Polyclonal Antibody is a valuable tool for researchers seeking to explore the role of CRTAM in biological processes. Its exceptional performance, reliability, and ease of use make it an indispensable asset in advancing scientific knowledge and contributing to the development of innovative therapeutic strategies.